An investigation has been launched on CHI Kozmetik İthalat İhracat San. ve Tic. AŞ, Ayaz ve Ortakları Ltd. Şti., Ege Teknoloji Kimya Mak. San. Tic. Ltd. Şti., SB Grup Kozmetik AŞ, Easyvit Sağlık Ürünleri Sanayi AŞ, ELCA Kozmetik Limited Şirketi, Farmatek İç ve Dış Tic. AŞ,  Cevher Kozmetik ve Sağlık Sanayi Ticaret AŞ, Glohe Bitkisel Ürünler San. ve Tic. AŞ, Kozmopol Kozmetik Sağlık Gıda San. ve Tic. AŞ, Hamzaoğlu Kimya San. ve Tic. AŞ, L'Oreal Türkiye Kozmetik San. ve Tic. AŞ, Neolife İthalat İhracat AŞ, Rebul JCR Kozmetik Paz. AŞ ve Sistem Kozmetik San. ve Tic Ltd. Şti.

The Competition Board concluded the preliminary inquiry into the allegation that the undertakings operating in the cosmetics and personal care products sector violated the Article 4 of Act no 4054 on the Protection of Competition (Act no 4054) by fixing resale prices of resellers, restricting online sales and joining in a hub-and-spoke cartel.

Discussing the information, documents and findings obtained in the preliminary inquiry during its meeting on 13.04.2023, the Competition Board concluded that the findings were sufficient and serious, and launched investigations on

• CHI Kozmetik İthalat İhracat San. ve Tic. AŞ to determine whether it violated Article 4 of the Act no 4054 for by fixing resale prices of resellers, with the decision numbered 23-18/343-M(2),
• Ayaz ve Ortakları Ltd. Şti. and SB Grup Kozmetik AŞ to determine whether they violated Article 4 of the Act no 4054 by joining the hub-and-spoke cartel, with the decision numbered 23-18/343-M(3),
• Easyvit Sağlık Ürünleri Sanayi AŞ, which operates in the cosmetics and personal care products sector, to determine whether it violated Article 4 of the Act 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(4),
• ELCA Kozmetik Limited Şirketi to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(5),
• Farmatek İç ve Dış Tic. AŞ to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(6),
• Cevher Kozmetik ve Sağlık Sanayi Ticaret AŞ, Glohe Bitkisel Ürünler San. ve Tic. AŞ and Kozmopol Kozmetik Sağlık Gıda San. ve Tic. AŞ to determine whether they violated Article 4 of the Act no 4054 by joining the hub-and-spoke cartel, and separately on Glohe Bitkisel Ürünler San. ve Tic. AŞ to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(7),
• Hamzaoğlu Kimya San. ve Tic. AŞ to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(8),
• L'Oreal Türkiye Kozmetik San. ve Tic. AŞ to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(9),
• Neolife İthalat İhracat AŞ to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting their online sales, with the decision numbered 23-18/343-M(10),
• Rebul JCR Kozmetik Paz. AŞ to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers and restricting online sales, with the decision numbered 23-18/343-M(11),
• Sistem Kozmetik San. ve Tic Ltd. Şti. to determine whether it violated Article 4 of Act no 4054 by fixing resale price of resellers and restricting online sales, with the decision numbered 23-18/343-M(12).

The Competition Board also decided

• to conclude via the settlement procedure the investigation on Ashley Joy Kozmetik Tic ve San. AŞ, launched pursuant to its decision numbered 23-18/343-M(1) to determine whether it violated Article 4 of the Act no 4054 by fixing resale prices of resellers,
• to conclude the investigation on Ege Teknoloji Kimya Mak. San. Tic. Ltd. Şti., launched pursuant to its decision numbered 23-18/343-M(3) o determine whether it violated Article 4 of the Act no 4054, via the settlement procedure with respect to the conduct related to the participation in the hub-and-spoke cartel and fixing resale prices,  and via commitments with respect to the conduct related to restricting internet sales,
• to conclude via settlement procedure the investigation on Farmakozmetika Sağlık Ürünleri ve Kozmetik Tic. Ltd. Şti., launched pursuant to its decision numbered 23-18/343-M(3) to determine whether it violated Article 4 of the Act no 4054 by joining the hub-and-spoke cartel.

* Investigation decisions taken by the Competition Board are announced to the public following the notification of the decision to the undertakings or associations of undertakings under investigation. These declarations, which are made within the framework of informing the public on Competition Board decisions, cannot be interpreted to mean that the undertakings or associations of undertakings under investigation have violated the Act no 4054 and that they have faced or will face sanctions under the Act.